Lundholm et al. identified that exosomes derived from prostate cancer cell expressed NKG2D ligands on their surface, which could induce the downregulation of NKG2D on natural killer (NK) cells and CD8 + T cells. The gene discussed is KLRK1; the disease is Familial prostate cancer.